Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 500 | $27.19 | $13,595.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 8 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 100 | $27.14 | $2,714.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 7 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 200 | $27.13 | $5,426.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 6 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 300 | $27.08 | $8,124.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 5 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,734 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 300 | $27.07 | $8,121.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 4 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,034 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 300 | $27.03 | $8,109.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 3 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,334 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
SaleCommon Stock | 700 | $27.00 | $18,900.00 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 2 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,634 F1 · kind: Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:08 UTC |
BRIMBLECOMBE ROGER WDirector
|
Exercise / conversionCommon Stock | 3,334 | $14.20 | $47,342.80 |
DisclosureSEC source: 0000875320-08-000021 · edgar.xml · nonDerivative · entry 1 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 500 | $27.41 | $13,705.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 20 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,301 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 322 | $27.19 | $8,755.18 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 19 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,801 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 200 | $27.16 | $5,432.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 18 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,123 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 500 | $27.15 | $13,575.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 17 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,323 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 300 | $27.10 | $8,130.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 16 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,823 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 478 | $27.10 | $12,953.80 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 15 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,123 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 300 | $27.09 | $8,127.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 14 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,601 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 500 | $27.05 | $13,525.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 13 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,901 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 400 | $27.04 | $10,816.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 12 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,401 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 200 | $27.02 | $5,404.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 11 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,801 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 400 | $27.01 | $10,804.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 10 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,001 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 80 | $27.70 | $2,216.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 9 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,401 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 100 | $27.46 | $2,746.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 8 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,481 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 50 | $27.26 | $1,363.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,581 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 70 | $27.20 | $1,904.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 6 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,631 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 580 | $27.11 | $15,723.80 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 5 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,701 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 150 | $27.07 | $4,060.50 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,281 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 75 | $27.03 | $2,027.25 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,431 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 475 | $27.00 | $12,825.00 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,506 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:09 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 50 | $26.99 | $1,349.50 |
DisclosureSEC source: 0000875320-08-000022 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,981 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 200 | $27.37 | $5,474.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 11 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 200 | $27.19 | $5,438.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 10 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,590 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 100 | $27.16 | $2,716.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 9 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,790 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 100 | $27.15 | $2,715.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 8 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,890 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 200 | $27.11 | $5,422.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 7 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,990 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 100 | $27.09 | $2,709.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 6 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,190 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 102 | $27.05 | $2,759.10 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,290 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 105 | $27.04 | $2,839.20 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,392 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 34 | $27.03 | $919.02 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,497 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 300 | $27.01 | $8,103.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,531 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:10 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 100 | $27.00 | $2,700.00 |
DisclosureSEC source: 0000875320-08-000023 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,831 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 258 | $27.70 | $7,146.60 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 10 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.46 | $5,492.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 9 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,540 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.27 | $5,454.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 8 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,740 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.20 | $5,440.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 7 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,940 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.13 | $5,426.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 6 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,140 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.08 | $5,416.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 5 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,340 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 300 | $27.07 | $8,121.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 4 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,540 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 300 | $27.03 | $8,109.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 3 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,840 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $27.00 | $5,400.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 2 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,140 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:12 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 200 | $26.99 | $5,398.00 |
DisclosureSEC source: 0000875320-08-000024 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,340 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 13, 2008 Filed May 15, 2008 19:16 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 200 | $27.63 | $5,526.00 |
DisclosureSEC source: 0000875320-08-000025 · edgar.xml · nonDerivative · entry 8 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,123 F1 · kind: Transaction made pursuant to Mr. Grave's company approved trading plan established under Rule 10b5-1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.